Epithelial to mesenchymal plasticity: role in cancer progression

Remya Raja, Akhilesh Pandey, Prashant Kumar

Research output: Contribution to journalArticle

Abstract

Epithelial-mesenchymal transition (EMT) is a dynamic process by which the cells transdifferentiate into two or more somatic states. The metastatic spread begins with tumor cells disseminated from the primary tumor via intravasation, hematogenous transit and extravasation to reach the distant organs to form micro- or macrometastasis. Dissemination of tumor cells or metastasis is a crucial stage in cancer progression and accounts for majority of cancer associated morbidity and mortality. Advances in technology has now enabled detection and capture of tumor cells that escape from primary site into the bloodstream. Such tumor cells which are found in transit in the blood are referred to as circulating tumor cells (CTCs) and they represent the early step in metastatic cascade. The dynamic changes in EMT phenotype in CTCs plays a key role in cancer metastasis. This review will focus on the role of EMT in cancer progression, circulating tumor cells and its clinical relevance.

Original languageEnglish (US)
Pages (from-to)838-873
Number of pages36
JournalFrontiers in bioscience (Landmark edition)
Volume25
DOIs
StatePublished - Jan 1 2020

Fingerprint

Plasticity
Tumors
Cells
Circulating Neoplastic Cells
Epithelial-Mesenchymal Transition
Neoplasms
Tumor Escape
Neoplasm Metastasis
Neoplasm Micrometastasis
Blood
Technology
Morbidity
Phenotype
Mortality

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Epithelial to mesenchymal plasticity : role in cancer progression. / Raja, Remya; Pandey, Akhilesh; Kumar, Prashant.

In: Frontiers in bioscience (Landmark edition), Vol. 25, 01.01.2020, p. 838-873.

Research output: Contribution to journalArticle

@article{0294edfed0c54fec910992b6569cc7e6,
title = "Epithelial to mesenchymal plasticity: role in cancer progression",
abstract = "Epithelial-mesenchymal transition (EMT) is a dynamic process by which the cells transdifferentiate into two or more somatic states. The metastatic spread begins with tumor cells disseminated from the primary tumor via intravasation, hematogenous transit and extravasation to reach the distant organs to form micro- or macrometastasis. Dissemination of tumor cells or metastasis is a crucial stage in cancer progression and accounts for majority of cancer associated morbidity and mortality. Advances in technology has now enabled detection and capture of tumor cells that escape from primary site into the bloodstream. Such tumor cells which are found in transit in the blood are referred to as circulating tumor cells (CTCs) and they represent the early step in metastatic cascade. The dynamic changes in EMT phenotype in CTCs plays a key role in cancer metastasis. This review will focus on the role of EMT in cancer progression, circulating tumor cells and its clinical relevance.",
author = "Remya Raja and Akhilesh Pandey and Prashant Kumar",
year = "2020",
month = "1",
day = "1",
doi = "10.2741/4837",
language = "English (US)",
volume = "25",
pages = "838--873",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",

}

TY - JOUR

T1 - Epithelial to mesenchymal plasticity

T2 - role in cancer progression

AU - Raja, Remya

AU - Pandey, Akhilesh

AU - Kumar, Prashant

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Epithelial-mesenchymal transition (EMT) is a dynamic process by which the cells transdifferentiate into two or more somatic states. The metastatic spread begins with tumor cells disseminated from the primary tumor via intravasation, hematogenous transit and extravasation to reach the distant organs to form micro- or macrometastasis. Dissemination of tumor cells or metastasis is a crucial stage in cancer progression and accounts for majority of cancer associated morbidity and mortality. Advances in technology has now enabled detection and capture of tumor cells that escape from primary site into the bloodstream. Such tumor cells which are found in transit in the blood are referred to as circulating tumor cells (CTCs) and they represent the early step in metastatic cascade. The dynamic changes in EMT phenotype in CTCs plays a key role in cancer metastasis. This review will focus on the role of EMT in cancer progression, circulating tumor cells and its clinical relevance.

AB - Epithelial-mesenchymal transition (EMT) is a dynamic process by which the cells transdifferentiate into two or more somatic states. The metastatic spread begins with tumor cells disseminated from the primary tumor via intravasation, hematogenous transit and extravasation to reach the distant organs to form micro- or macrometastasis. Dissemination of tumor cells or metastasis is a crucial stage in cancer progression and accounts for majority of cancer associated morbidity and mortality. Advances in technology has now enabled detection and capture of tumor cells that escape from primary site into the bloodstream. Such tumor cells which are found in transit in the blood are referred to as circulating tumor cells (CTCs) and they represent the early step in metastatic cascade. The dynamic changes in EMT phenotype in CTCs plays a key role in cancer metastasis. This review will focus on the role of EMT in cancer progression, circulating tumor cells and its clinical relevance.

UR - http://www.scopus.com/inward/record.url?scp=85072937501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072937501&partnerID=8YFLogxK

U2 - 10.2741/4837

DO - 10.2741/4837

M3 - Article

C2 - 31585920

AN - SCOPUS:85072937501

VL - 25

SP - 838

EP - 873

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

ER -